FTC Investigates Drug Company Merger

The Federal Trade Commission has issued a second request delaying the proposed $41.1 billion merger between Merck & Co. Inc. and Schering-Plough Corp. 

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*